Cemalettin Yilmaz, Büşra Güvendi Şengör, Regayip Zehir, Ahmet Ferhat Kaya, Mehmet Hasan Özdil, Barkin Kültürsay
{"title":"宽脉压作为初步经皮冠状动脉介入治疗的糖尿病患者造影剂引起的急性肾损伤的新预测因子。","authors":"Cemalettin Yilmaz, Büşra Güvendi Şengör, Regayip Zehir, Ahmet Ferhat Kaya, Mehmet Hasan Özdil, Barkin Kültürsay","doi":"10.1097/MBP.0000000000000738","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary percutaneous coronary intervention (p-PCI) is pivotal in managing ST-segment elevation myocardial infarction (STEMI); however, it introduces potential risks, such as contrast-induced acute kidney injury (CI-AKI). This study aimed to investigate the relationship between pulse pressure (PP) and CI-AKI incidence in diabetic patients.</p><p><strong>Methods: </strong>In this retrospective study conducted between 2021 and 2022, 590 diabetic STEMI patients undergoing p-PCI were categorized based on the presence of wide PP. Individuals with PP ≥ 65 mmHg were classified as the 'wide PP (+) group', while those with PP < 65 mmHg were classified as the 'wide PP (-) group'. To determine independent predictors of CI-AKI, multivariable logistic regression models were applied. After establishing the base model, blood pressure indices, including PP, SBP, DBP, mean arterial pressure, and pulsatility were added to the model using the stepwise selection method.</p><p><strong>Results: </strong>Among the patients, 18.3% ( n = 108) were in the wide PP (+) group, while 81.7% ( n = 482) were in the wide PP (-) group. The incidence of hypertension, SBP, PP, and the risk of CI-AKI were higher in the wide PP (+) group. Multivariable analysis recognized PP, wide PP, and pulsatility as independent CI-AKI predictors [odds ratio (OR): 1.024, 95% confidence interval (CI): 1.003-1.045, P = 0.025; OR: 1.684, 95% CI: 1.025-2.769, P = 0.040; OR: 13.816, 95% CI: 2.069-92.245, P = 0.007, respectively].</p><p><strong>Conclusion: </strong>Increased PP emerges as an independent predictor for CI-AKI in diabetic patients undergoing p-PCI.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"65-72"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Wide pulse pressure as a novel predictor of contrast-induced acute kidney injury in diabetic patients undergoing primary percutaneous coronary intervention.\",\"authors\":\"Cemalettin Yilmaz, Büşra Güvendi Şengör, Regayip Zehir, Ahmet Ferhat Kaya, Mehmet Hasan Özdil, Barkin Kültürsay\",\"doi\":\"10.1097/MBP.0000000000000738\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Primary percutaneous coronary intervention (p-PCI) is pivotal in managing ST-segment elevation myocardial infarction (STEMI); however, it introduces potential risks, such as contrast-induced acute kidney injury (CI-AKI). This study aimed to investigate the relationship between pulse pressure (PP) and CI-AKI incidence in diabetic patients.</p><p><strong>Methods: </strong>In this retrospective study conducted between 2021 and 2022, 590 diabetic STEMI patients undergoing p-PCI were categorized based on the presence of wide PP. Individuals with PP ≥ 65 mmHg were classified as the 'wide PP (+) group', while those with PP < 65 mmHg were classified as the 'wide PP (-) group'. To determine independent predictors of CI-AKI, multivariable logistic regression models were applied. After establishing the base model, blood pressure indices, including PP, SBP, DBP, mean arterial pressure, and pulsatility were added to the model using the stepwise selection method.</p><p><strong>Results: </strong>Among the patients, 18.3% ( n = 108) were in the wide PP (+) group, while 81.7% ( n = 482) were in the wide PP (-) group. The incidence of hypertension, SBP, PP, and the risk of CI-AKI were higher in the wide PP (+) group. Multivariable analysis recognized PP, wide PP, and pulsatility as independent CI-AKI predictors [odds ratio (OR): 1.024, 95% confidence interval (CI): 1.003-1.045, P = 0.025; OR: 1.684, 95% CI: 1.025-2.769, P = 0.040; OR: 13.816, 95% CI: 2.069-92.245, P = 0.007, respectively].</p><p><strong>Conclusion: </strong>Increased PP emerges as an independent predictor for CI-AKI in diabetic patients undergoing p-PCI.</p>\",\"PeriodicalId\":8950,\"journal\":{\"name\":\"Blood Pressure Monitoring\",\"volume\":\" \",\"pages\":\"65-72\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Pressure Monitoring\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MBP.0000000000000738\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Pressure Monitoring","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MBP.0000000000000738","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:原发性经皮冠状动脉介入治疗(p-PCI)是治疗st段抬高型心肌梗死(STEMI)的关键;然而,它引入了潜在的风险,如造影剂诱导的急性肾损伤(CI-AKI)。本研究旨在探讨糖尿病患者脉压(PP)与CI-AKI发生率的关系。方法:在这项于2021年至2022年进行的回顾性研究中,590名接受p-PCI治疗的糖尿病STEMI患者根据宽PP的存在进行分类。PP≥65 mmHg的个体被归类为“宽PP(+)组”,而PP患者则被归类为“宽PP(+)组”。结果:18.3% (n = 108)的患者属于宽PP(+)组,81.7% (n = 482)的患者属于宽PP(-)组。宽PP(+)组高血压、收缩压、PP发生率和CI-AKI风险较高。多变量分析发现PP、宽PP和脉搏是独立的CI- aki预测因子[比值比(OR): 1.024, 95%可信区间(CI): 1.003-1.045, P = 0.025;Or: 1.684, 95% ci: 1.025-2.769, p = 0.040;OR: 13.816, 95% CI: 2.069-92.245, P = 0.007]。结论:PP升高是行p-PCI的糖尿病患者CI-AKI的独立预测因子。
Wide pulse pressure as a novel predictor of contrast-induced acute kidney injury in diabetic patients undergoing primary percutaneous coronary intervention.
Background: Primary percutaneous coronary intervention (p-PCI) is pivotal in managing ST-segment elevation myocardial infarction (STEMI); however, it introduces potential risks, such as contrast-induced acute kidney injury (CI-AKI). This study aimed to investigate the relationship between pulse pressure (PP) and CI-AKI incidence in diabetic patients.
Methods: In this retrospective study conducted between 2021 and 2022, 590 diabetic STEMI patients undergoing p-PCI were categorized based on the presence of wide PP. Individuals with PP ≥ 65 mmHg were classified as the 'wide PP (+) group', while those with PP < 65 mmHg were classified as the 'wide PP (-) group'. To determine independent predictors of CI-AKI, multivariable logistic regression models were applied. After establishing the base model, blood pressure indices, including PP, SBP, DBP, mean arterial pressure, and pulsatility were added to the model using the stepwise selection method.
Results: Among the patients, 18.3% ( n = 108) were in the wide PP (+) group, while 81.7% ( n = 482) were in the wide PP (-) group. The incidence of hypertension, SBP, PP, and the risk of CI-AKI were higher in the wide PP (+) group. Multivariable analysis recognized PP, wide PP, and pulsatility as independent CI-AKI predictors [odds ratio (OR): 1.024, 95% confidence interval (CI): 1.003-1.045, P = 0.025; OR: 1.684, 95% CI: 1.025-2.769, P = 0.040; OR: 13.816, 95% CI: 2.069-92.245, P = 0.007, respectively].
Conclusion: Increased PP emerges as an independent predictor for CI-AKI in diabetic patients undergoing p-PCI.
期刊介绍:
Blood Pressure Monitoring is devoted to original research in blood pressure measurement and blood pressure variability. It includes device technology, analytical methodology of blood pressure over time and its variability, clinical trials - including, but not limited to, pharmacology - involving blood pressure monitoring, blood pressure reactivity, patient evaluation, and outcomes and effectiveness research.
This innovative journal contains papers dealing with all aspects of manual, automated, and ambulatory monitoring. Basic and clinical science papers are considered although the emphasis is on clinical medicine.
Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.